Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials (Q36731119)

15 August 2017

0 references

Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials (English)

1 reference

15 August 2017

0 references

1 reference

1 reference

Rosenfeldt FL

1

1 reference

15 August 2017

Haas SJ

2

1 reference

15 August 2017

Krum H

3

1 reference

15 August 2017

Hadj A

4

1 reference

15 August 2017

Ng K

5

1 reference

15 August 2017

Leong JY

6

1 reference

15 August 2017

Watts GF

7

1 reference

15 August 2017

8 February 2007

1 reference

Journal of Human Hypertension

15 August 2017

1 reference

15 August 2017

21

1 reference

15 August 2017

4

1 reference

15 August 2017

297-306

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.jhh.1002138

15 August 2017

0 references

cites work

An epidemiologic perspective of systemic hypertension, ischemic heart disease, and heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Coenzyme Q10 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Overview of the use of CoQ10 in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Plasma coenzyme Q (ubiquinone) concentrations in patients treated with simvastatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Strengths and limitations of meta-analysis: larger studies may be more reliable

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

21 January 2018

Meta-Analysis in Stata™

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. CoQ10 Drug Surveillance Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Malondialdehyde, lipofuscin and activity of antioxidant enzymes during physical exercise in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

7 January 2021

Coenzyme Q10 in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

7 January 2021

Treatment of essential hypertension with coenzyme Q10

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

7 January 2021

Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

7 January 2021

Lipophilic HMG-CoA reductase inhibitors increase myocardial stunning in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

7 January 2021

Cellular redox poise modulation; the role of coenzyme Q10, gene and metabolic regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1002138

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1002138

1 reference

15 August 2017

1 reference